Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...

Rockville Centre became the first diocese in New York with a confirmed reorganization plan, providing a potential blueprint ...

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

Gibson called for more funds to be allocated for mobile units to care for drug users in the Bronx; Naloxone training for residents and caregivers; and an ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.

Long Island Congressman Nick Lalota is part of a group planning to hold up the nation's tax bill if the cap is not nixed. CBS ...

Multiple states have reached a tentative new agreement with the Sackler family, who made billions of dollars marketing OxyContin, the drug that set off the U.S. opioid crisis. New York State Attorney ...

New York Gov. Kathy Hochul has unveiled her plan to make community college free for adult learners. Kournikova, who stays ...

A settlement agreement with Purdue Pharma and members of the Sackler family, could bring in another $250 million to New York ...

The money could benefit the 14 syringe service programs across the five boroughs that offer harm reduction services.

Objections to Johnson & Johnson's talc bankruptcy plan cite the U.S. Supreme Court's decision last year invalidating nonconsensual releases in Purdue Pharma's $6 billion opioid settlement.